HF
COGT icon

HRT Financial’s Cogent Biosciences COGT Stock Holding History

HRT Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-81,340
Closed -$2.89M – 3919
2025
Q4 		$2.89M Buy
+81,340
New +$2.29M 0.01% 1069
2025
Q1 		– Sell
-57,056
Closed -$445K – 2623
2024
Q4 		$445K Buy
+57,056
New +$569K ﹤0.01% 1520
2024
Q1 		– Sell
-90,215
Closed -$530K – 2423
2023
Q4 		$530K Buy
+90,215
New +$691K ﹤0.01% 1329
2021
Q2 		– Sell
-60,012
Closed -$526K – 2939
2021
Q1 		$526K Buy
+60,012
New +$578K 0.01% 1733

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

HRT Financial's COGT Position: Q1 2026 in Review

HRT Financial sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 81,340 shares — an estimated $2.89M sold.

HRT Financial first reported a position in COGT in Q1 2021 and held it in 4 quarters. The position peaked at $2.89M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • HRT Financial reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 81,340 Cogent Biosciences shares in Q1 2026, an estimated $2.89M.
  • HRT Financial first reported a position in Cogent Biosciences in Q1 2021 and held it in 4 quarters.
  • HRT Financial's Cogent Biosciences position peaked at $2.89M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.